143 related articles for article (PubMed ID: 31693188)
61. Primary cutaneous follicle center lymphoma of the arm with a novel chromosomal translocation t(12;21)(q13;q22): a case report.
Jelic TM; Berry PK; Jubelirer SJ; Plumley L; Hartel PH; Estalilla OC; Chang HH
Am J Hematol; 2006 Jun; 81(6):448-53. PubMed ID: 16680749
[TBL] [Abstract][Full Text] [Related]
62. Acneiform presentation of primary cutaneous follicle center lymphoma.
Soon CWM; Pincus LB; Ai WZ; McCalmont TH
J Am Acad Dermatol; 2011 Oct; 65(4):887-889. PubMed ID: 21920255
[No Abstract] [Full Text] [Related]
63. Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant.
Kempf W; Kazakov DV; Rütten A; Rupec RA; Talarcik P; Ballová V; Kerl K; Dummer R; Lautenschlager S; Zimmermann DR; Tinguely M
J Am Acad Dermatol; 2014 Sep; 71(3):548-54. PubMed ID: 24836545
[TBL] [Abstract][Full Text] [Related]
64. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
65. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
66. Paraffin immunoreactivity of CD10, CDw75, and Bcl-6 in follicle center cell lymphoma.
Dunphy CH; Polski JM; Lance Evans H; Gardner LJ
Leuk Lymphoma; 2001 May; 41(5-6):585-92. PubMed ID: 11378576
[TBL] [Abstract][Full Text] [Related]
67. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage.
Adam P; Katzenberger T; Eifert M; Ott MM; Rosenwald A; Müller-Hermelink HK; Ott G
Am J Surg Pathol; 2005 Dec; 29(12):1661-4. PubMed ID: 16327439
[TBL] [Abstract][Full Text] [Related]
68. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
69. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
Hristov AC
Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
[TBL] [Abstract][Full Text] [Related]
70. [Cutaneous B cell processes with nodular pattern].
Chirife AM; Bilbao ER; Giménez L; Marino L
Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
[TBL] [Abstract][Full Text] [Related]
71. Primary cutaneous follicle center lymphoma following deep brain stimulation implants.
Kim S; Diaz LZ; Duvic M
Leuk Lymphoma; 2013 Aug; 54(8):1806-7. PubMed ID: 23294327
[No Abstract] [Full Text] [Related]
72. Contribution of conventional photodynamic therapy in the treatment of primary cutaneous follicle center lymphoma.
Chaabani M; Ben Lagha I; Ben Tanfous A; Koubaa W; Ben Brahim E; Fenniche S; Zaouak A; Hammami-Ghorbel H
Int J Dermatol; 2020 Jun; 59(6):e204-e206. PubMed ID: 32043563
[No Abstract] [Full Text] [Related]
73. Primary cutaneous follicle center lymphoma simulating basal-cell carcinoma on the nasal ala.
Wanczinsnki MI; Pinto CA; Trevisan F; Cunha PR; Grohs LM
An Bras Dermatol; 2015; 90(3 Suppl 1):111-4. PubMed ID: 26312690
[TBL] [Abstract][Full Text] [Related]
74. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases.
Franco R; Fernandez-Vazquez A; Rodriguez-Peralto JL; Bellas C; López-Ríos F; Sáez A; Villuendas R; Navarrete M; Fernandez I; Zarco C; Piris MA
Am J Surg Pathol; 2001 Jul; 25(7):875-83. PubMed ID: 11420458
[TBL] [Abstract][Full Text] [Related]
75. The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade.
Lawnicki LC; Weisenburger DD; Aoun P; Chan WC; Wickert RS; Greiner TC
Am J Clin Pathol; 2002 Nov; 118(5):765-72. PubMed ID: 12428798
[TBL] [Abstract][Full Text] [Related]
76. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
[TBL] [Abstract][Full Text] [Related]
77. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
[TBL] [Abstract][Full Text] [Related]
78. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
79. Leukocyte common antigen (CD45) negative follicular lymphoma, a rare immunophenotypic presentation.
Wang F; Xu D; Cui W
Clin Chim Acta; 2015 Mar; 442():46-8. PubMed ID: 25562817
[TBL] [Abstract][Full Text] [Related]
80. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
